BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 27, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 16, 2000
View Archived Issues
NPS Moves Into Phase III Trial With Drug For Osteoporosis
Read More
SuperGen, Emisphere, BioPure All Register For Public Offerings
Read More
COR Offers $150M Convertible Subordinated Notes Due 2007
Read More
Other News To Note
Read More
3-Dimensional In $9M Deal With DuPont For Discovery
Read More
Genentech, Actelion In $75M Agreement For Heart Drug
Read More
Three Biotechs Form Curis To Focus on Tissue Regeneration
Read More
Innovation, Funding Expected To Continue Fueling Industry
Read More
Pediatric Scientists Try Out FDA-Approved Orphan Drug On Less Rare a-1-Antitrypsin Deficiency
Read More
